Hotline: 1800 102 2007
Hotline: 1800 102 2007
Search Business Opportunities
Merger 2015-03-09

Apex court of Punjab and Haryana orally approves Ranbaxy, Sun Pharma merger

Sun Pharma announced the $4 billion deal to buy Ranbaxy in April 2014. One year down the line, the High Courts of Punjab and Haryana have orally approved the merger of the pharma majors.

Apex court of Punjab and Haryana orally approves Ranbaxy, Sun Pharma merger

Approving the Scheme of Arrangement involving merger of Ranbaxy Laboratories with Sun Pharmaceutical Industries, the High Court of Punjab and Haryana has orally approved the merger of two biggies.


According to Sun Pharmaceutical, a certified true copy of the court order is awaited.


Reportedly, the US Federal Trade Commission (FTC) recently approved the proposed $4-billion buyout of Ranbaxy by Sun Pharma. It completed its review of the deal and has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.


FTC accepted a proposed consent agreement following which Sun Pharma and Ranbaxy have agreed to divest Ranbaxy’s interests in generic minocycline tablets and capsules to an external third party.


Generic minocycline tablets are used to treat an array of bacterial infections, including pneumonia, acne and urinary tract infections.


In December, the Indian fair trade regulator Competition Commission of India (CCI) had approved the mega deal with certain riders. As per the conditions, CCI directed both the companies to divest seven products as it found that the deal could hit competition in the Indian market.


Last April, Sun Pharma announced that it would take control on Ranbaxy in an all-stock transaction with a total equity value of $3.2 billion, along with debt of $800 million, taking the overall deal value to $4 billion.


This would be the biggest domestic Merger & Acquisition (M&A) deal ever and by far the top Pharma deal in local currency terms.


Significantly, once completed, the deal would create India’s largest and world’s fifth-biggest drug maker with operations across 65 countries, 47 manufacturing facilities in five continents and a global portfolio of specialty and generic products.

Comment
image
image
image
image
Related opportunities
  • ABOUT US : We build bicycles for every age group. Ryder..
    Locations looking for expansion Maharashtra
    Establishment year 2012
    Franchising Launch Date 2019
    Investment size Rs. 20lac - 30lac
    Space required 800
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Mumbai Maharashtra
  • Casual dine Restaurants
    About Us: Company is into F&B Business with concepts such as..
    Locations looking for expansion Karnataka
    Establishment year 2011
    Franchising Launch Date 2018
    Investment size Rs. 20lac - 30lac
    Space required 500
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Bangalore Karnataka
  • Kids Entertainment Zones
    About Us: Launched in 2012, SMAAASH is one of India's acclaimed..
    Locations looking for expansion Delhi
    Establishment year 2012
    Franchising Launch Date 2011
    Investment size Rs. 2 Cr. - 5 Cr
    Space required 5000
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater new Delhi Delhi
  •  About Us: If you have a small shop or an established..
    Locations looking for expansion Maharashtra
    Establishment year 2015
    Franchising Launch Date 2017
    Investment size Rs. 10000 - 50 K
    Space required 50
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Thane Maharashtra
Insta-Subscribe to
The Franchising World
Magazine
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities
More Stories

Free Advice - Ask Our Experts